Four elements carry most of the decision in prevention: HbA1c, lipids read against global risk, kidney function and blood pressure. Trendy markers arrive far behind, and several of them vary more than the difference one seeks to measure. A test is worth only what it predicts, and the decision it changes.
This guide gathers the analyses the School devotes to biomarkers and prevention. Each answers a real consultation scene: a person arrives with a result, and one must know what can be said about it.
The foundation fits into four elements, and it is remeasured
A prevention panel starts with a standardized cardiometabolic foundation, and its value comes less from the first number than from remeasurement under comparable conditions. Same laboratory, same time of day, same fasting state. Without that, the difference between two panels mixes the person's evolution with the variability of the method.
The rest of the work consists in classifying each value and setting a remeasurement date. That is where the difference lies between a panel that serves and a list of numbers commented once and then forgotten.
Fasting glucose is the last marker to move
Normal fasting glucose does not say that a metabolism is well. Insulin resistance sets in years before sugar rises, and this window is what matters in coaching. The same number does not carry the same weight depending on the context in which it is read.
Orders of magnitude are known: prediabetes multiplies risk, and lifestyle does better than metformin in the trial that compared the two. Exercise acts on the marker without going through the scale, which changes the conversation to have with a person whose weight does not move.
High ferritin is almost never iron overload
The scene repeats every week: a ferritin above the reference range, someone has said the word hemochromatosis, sometimes the word bloodletting. In the vast majority of cases, iron is not the cause. Ferritin also rises with inflammation, alcohol and fatty liver.
One other test settles the direction of the workup, transferrin saturation. The most frequent case in practice is metabolic, not genetic. Hemochromatosis exists and is inherited, and its investigation belongs to the physician.
A slightly high TSH does not explain fatigue
TSH is the most requested test in the face of persistent fatigue, and the box most often ticked to explain what is wrong. Two large trials tested the idea directly: correcting a slightly elevated TSH improves neither fatigue nor symptoms. Twenty-one trials reach the same result.
There is something more troubling for the shortcut: in about a third of cases, the number comes back down on its own with no intervention. Fatigue therefore remains a poor entry point to the thyroid, and interpretation of the test is the physician's call.
what a slightly high TSH changes, and what it does not change
Salivary cortisol does not support adrenal fatigue
A systematic review of 58 studies looked at whether cortisol measurements supported the concept of adrenal fatigue. The answer is no, and the reason lies as much in the measurement method as in the hypothesis. Variability from one sample to another often exceeds the difference being sought.
Capillary cortisol, presented as the solution to that problem, does not solve it. Cortisol excess exists in pathology, and it has another face than chronic fatigue. What remains to offer an exhausted person is documented, and does not go through a salivary kit.
Vitamin D: the error runs both ways
Twenty-five thousand participants followed for five years, and no reduction in fractures in the general population. The result surprised, and it does not allow the opposite conclusion: the effect exists elsewhere, at a moderate daily dose and in people who are deficient. On falls, the dose and the rhythm of intake change the result.
The 2024 recommendation moves the question from dose to age, which modifies management in routine practice. The frequent error runs both ways: supplementing without deficiency, or leaving an established deficiency unaddressed.
Supplements are classified by the outcome measured in trials
A supplement is not judged on its mechanism but on what trials measured. Vitamin D shows a documented benefit only in deficiency. Antioxidants provide no benefit in mortality prevention. NAD+ related molecules are still evaluated on surrogate markers.
Three constraints bound any supplementation: overdose, interactions with ongoing treatment, and opportunity cost. Targeted supplementation is documented, dosed and reassessed at three months, or it serves no purpose.
A biological age is worth only its predictive value
The term covers methods with no relation to each other. The most useful comparison involved 9,389 people from the NHANES III survey followed for eighteen years, with 1,843 deaths: one method came out ahead, and when it is placed in the same model as chronological age, chronological age ceases to be associated with mortality. That is the only argument that counts.
Measurement noise, for its part, often exceeds the difference being sought. A paper published in 2022 ran six clocks on duplicated samples: the same sample, analyzed twice, produced differences of up to nine years. Two free measures already predict a great deal, walking speed and grip strength.
Epigenetic clocks remain a research tool
Clocks read DNA methylation at thousands of sites and translate it into a number. DunedinPACE does not give an age but a rate of aging, which is another question. The result reads as a reflection of trajectory, not as an individual verdict.
Two technical limits are enough to explain the caution: methylation varies with the tissue sampled and with the analysis platform. Consumer offers remain outside the frame of a prescription, and the useful consultation is the one where the person arrives already with their result.
Before any test, validated and free instruments
Most first consultations begin with a home made questionnaire. Yet validated, free instruments exist, whose sensitivity, specificity and gap with objective measurement are known. One still needs to know which rules out a disorder and which quantifies nothing.
Two gaps are systematic and useful to know: declared activity is not activity done, and five questions are enough to spot muscle frailty. A questionnaire serves to rule out, not to quantify, and the interview adds what the form does not capture.
Knowing when to hand over, and when not to
Every non-physician practitioner knows the instruction: refer when there is a warning signal. Nobody ever says which ones, or what they are worth. The data exist and surprise in both directions. Several red flags taught everywhere have no validation, and unintentional weight loss deserves the detour.
Over-referral also costs something, in trust and in access to care. Before intense effort, the main risk is even of referring too much. Referring is a technical decision, not a confession, and it holds in three steps.
| Marker | What it predicts | Decision it changes |
|---|---|---|
| HbA1c | Metabolic risk | Yes, after confirmation |
| Lipids | Global cardiovascular risk | Yes, read with the rest of the profile |
| Blood pressure | Mild cognitive impairment, events | Yes, best demonstrated lever |
| Fasting glucose alone | Little, and late | No, it moves last |
| Ferritin | Inflammation more often than iron | No without transferrin saturation |
| Slightly high TSH | Not fatigue | No, a third normalize on their own |
| Salivary cortisol | Nothing validated on fatigue | No |
| 25-OH vitamin D | Deficiency, in those likely to have it | Yes in case of deficiency |
| Epigenetic clocks | Population trajectory | No individually, up to 9 years of noise |
| Walking speed, grip strength | Mortality, independence | Yes, and free |
What each marker predicts and the decision it allows, or does not allow.
The analyses in this guide
- Vitamin B12: the deficiency signs the studies really confirm
- High cortisol and adrenal fatigue: the truth about the tests
- Thyroid and fatigue: what a slightly high TSH really means
- High ferritin: why it is almost never iron overload
- Insulin resistance without diabetes: what the number reaches, and the levers that push it back
- Biological age: the real value of the measures, and their blind spots
- Medical referral: which signals require handing over, and which do not
- First consultation questionnaire: which validated tools, and what they can do
- Vitamin D: the claims the large trials allow, and the ones they do not
- Anti-aging supplements: the evidence on one side, the promises on the other
- Prevention blood panel: the useful markers and their limits
- Epigenetic clocks: real usefulness and limits in practice
Questions
Which tests should be requested for a longevity panel?
Prescribing is the physician's domain. The foundation that carries most of the decision is known: HbA1c, a lipid panel read with global risk, kidney function and blood pressure. What gives follow-up its value is not the length of the list, it is remeasurement under comparable conditions.
Are biological age tests sold online reliable?
Not at the individual level. A 2022 paper ran six epigenetic clocks on duplicated samples: the same sample analyzed twice produced differences of up to nine years, more than the difference a practitioner hopes to observe after a year of coaching.
Can a non-physician practitioner interpret a blood panel?
No. Interpretation of a panel, diagnosis and prescription are the physician's domain. A practitioner can explain what a marker measures, recall what trials show, work the lifestyle levers and refer when a result falls outside the frame.
Does adrenal fatigue exist?
A systematic review of 58 studies concluded that cortisol measurements do not support this concept. Measurement variability often exceeds the difference being sought, and capillary cortisol does not solve that problem. Pathological cortisol excess exists, with a different presentation.
Which free marker is worth following?
Two: walking speed and grip strength. They predict mortality and independence, they cost nothing, and they are remeasured under the same conditions without depending on a laboratory or an analysis platform.